HOME » INVESTORS: NEWS RELEASES

2007 NEWS RELEASES
Thursday, December 13, 2007(PDF)
- MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
Monday, December 3, 2007(PDF)
- MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study Four-Week
Interim Results
Friday, November 30, 2007(PDF) -
MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call &
Webcast Notification
Wednesday, October 31, 2007(PDF)
- MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual
Healthcare Conference
Wednesday, October 17, 2007(PDF)
- Omiganan Phase II Rosacea Study Demonstrates Promising Results,
Partner Plans to Advance to Phase III
Thursday,
September 20, 2007(PDF) - MIGENIX to Present at UBS 2007 Global Life
Sciences Conference
Tuesday September
11, 2007(PDF) - MIGENIX Reports First Quarter Fiscal Year 2008
Financial Results
Monday, September
10, 2007(PDF) - MIGENIX to Present Positive Celgosivir Viral
Resistance Data at International HCV Meeting
Click Here
for Poster
Click
Here for Abstract
Thursday, September 6, 2007(PDF) - MIGENIX First Fiscal Quarter 2008
Financial Results Conference Call & Webcast Notification
Tuesday, August 7, 2007(PDF) - MIGENIX to Present at Canaccord
Adams’ 27th Global Growth Conference
Monday, July 30, 2007(PDF) - MIGENIX Partner Cadence Pharmaceuticals
Gets FDA Agreement on Enrollment in Phase III Clinical Trial of Omigard™ for
Preventing Catheter-Related Infections
Wednesday, July 18, 2007(PDF) -
MIGENIX Reports Fourth
Quarter and Fiscal Year 2007 Financial Results
Tuesday, July 10, 2007(PDF) -
MIGENIX Fourth Quarter Fiscal Year 2007 Financial Results Conference Call &
Web Cast Notification
Thursday, July 5, 2007
(PDF) -
MIGENIX Releases CEO Message #21
Wednesday, June 27, 2007 (PDF) -
Update on MIGENIX
Agreement with Schering-Plough for Hepatitis C Virus Treatment
Friday, May 18, 2007
(PDF) -
MIGENIX to Present
Celgosivir Phase II Hepatitis C Results at Digestive Disease Week 2007
Friday, May
11, 2007
(PDF) -
MIGENIX to Present at
the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 4, 2007
(PDF) -
MIGENIX Releases CEO Message #20
May 1, 2007
(PDF) -
MIGENIX Partner Cadence Pharmaceuticals To Increase Size of Phase III
Clinical Trial of Omigard™
April 11, 2007 (PDF) -
MIGENIX Reports
New Clinical Study Results Indicate Higher
Early Virologic Response With Celgosivir Combination Therapy in HCV
Non-Responders
March 13, 2007
(PDF) -
MIGENIX Third Quarter Fiscal Year 2007 Financial Results
March 5, 2007
(PDF) -
MIGENIX Third Quarter Fiscal Year 2007 Financial Results Conference Call &
Web Cast Notification
February 6, 2007
(PDF) - MIGENIX Provides Update on License-Option Agreement with
Schering-Plough for Celgosivir in Hepatitis C
January 22, 2007
(PDF) - MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by
Partner, Cutanea Life Sciences
|